← feed

Is NCT03159416 results overdue?

Yes — results are overdue. Primary completion was 2018-03-24; the FDAAA-801 reporting deadline (2019-03-24) passed 2692 days ago and no results are posted on ClinicalTrials.gov.

A Study of Inclisiran in Participants With Renal Impairment Compared to Participants With Normal Renal Function (ORION-7)

NCT IDNCT03159416 ↗
SponsorThe Medicines Company (INDUSTRY)
PhasePHASE1
StatusCOMPLETED
Primary completion2018-03-24 (ACTUAL)
Reporting deadline2019-03-24 (completion + 365d)
Days overdue2692
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 91fd37534acc6b23… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03159416. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →